Banks - Regional
Compare Stocks
2 / 10Stock Comparison
BMA vs GS
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Capital Markets
BMA vs GS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Banks - Regional | Financial - Capital Markets |
| Market Cap | $4.84B | $291.19B |
| Revenue (TTM) | $6.46T | $126.85B |
| Net Income (TTM) | $291.41B | $16.67B |
| Gross Margin | 68.3% | 41.1% |
| Operating Margin | 5.6% | 14.5% |
| Forward P/E | 0.0x | 15.8x |
| Total Debt | $465.41B | $616.93B |
| Cash & Equiv. | $2.78T | $182.09B |
BMA vs GS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Banco Macro S.A. (BMA) | 100 | 448.5 | +348.5% |
| The Goldman Sachs G… (GS) | 100 | 477.0 | +377.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BMA vs GS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BMA is the clearest fit if your priority is valuation efficiency and bank quality.
- PEG 0.00 vs GS's 1.13
- NIM 11.1% vs GS's 0.5%
- Lower P/E (0.0x vs 15.8x), PEG 0.00 vs 1.13
GS carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 12 yrs, beta 1.47, yield 1.4%
- Rev growth 17.0%, EPS growth 77.3%
- 5.4% 10Y total return vs BMA's 56.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 17.0% NII/revenue growth vs BMA's -33.3% | |
| Value | Lower P/E (0.0x vs 15.8x), PEG 0.00 vs 1.13 | |
| Quality / Margins | Efficiency ratio 0.3% vs BMA's 0.6% (lower = leaner) | |
| Stability / Safety | Beta 1.47 vs BMA's 1.76 | |
| Dividends | 6.8% yield, 1-year raise streak, vs GS's 1.4% | |
| Momentum (1Y) | +73.4% vs BMA's -6.5% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs BMA's 0.6% |
BMA vs GS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BMA vs GS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
GS leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
BMA is the larger business by revenue, generating $6.46T annually — 51.0x GS's $126.9B. GS is the more profitable business, keeping 11.3% of every revenue dollar as net income compared to BMA's 5.0%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $6.46T | $126.9B |
| EBITDAEarnings before interest/tax | $620.9B | $23.4B |
| Net IncomeAfter-tax profit | $291.4B | $16.7B |
| Free Cash FlowCash after capex | -$2.44T | $15.8B |
| Gross MarginGross profit ÷ Revenue | +68.3% | +41.1% |
| Operating MarginEBIT ÷ Revenue | +5.6% | +14.5% |
| Net MarginNet income ÷ Revenue | +5.0% | +11.3% |
| FCF MarginFCF ÷ Revenue | +12.3% | -12.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -136.4% | +45.8% |
Valuation Metrics
BMA leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 21.1x trailing earnings, BMA trades at a 9% valuation discount to GS's 23.1x P/E. Adjusting for growth (PEG ratio), BMA offers better value at 0.41x vs GS's 1.65x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $4.8B | $291.2B |
| Enterprise ValueMkt cap + debt − cash | $3.2B | $726.0B |
| Trailing P/EPrice ÷ TTM EPS | 21.07x | 23.12x |
| Forward P/EPrice ÷ next-FY EPS est. | 0.01x | 15.84x |
| PEG RatioP/E ÷ EPS growth rate | 0.41x | 1.65x |
| EV / EBITDAEnterprise value multiple | 8.89x | 34.92x |
| Price / SalesMarket cap ÷ Revenue | 1.04x | 2.30x |
| Price / BookPrice ÷ Book value/share | 1.69x | 2.56x |
| Price / FCFMarket cap ÷ FCF | 8.49x | — |
Profitability & Efficiency
BMA leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
GS delivers a 12.6% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $6 for BMA. BMA carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to GS's 5.06x. On the Piotroski fundamental quality scale (0–9), BMA scores 6/9 vs GS's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +6.1% | +12.6% |
| ROA (TTM)Return on assets | +1.4% | +0.9% |
| ROICReturn on invested capital | +5.5% | +1.9% |
| ROCEReturn on capital employed | +5.5% | +3.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.11x | 5.06x |
| Net DebtTotal debt minus cash | -$2.31T | $434.8B |
| Cash & Equiv.Liquid assets | $2.78T | $182.1B |
| Total DebtShort + long-term debt | $465.4B | $616.9B |
| Interest CoverageEBIT ÷ Interest expense | 0.28x | 0.31x |
Total Returns (Dividends Reinvested)
Evenly matched — BMA and GS each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BMA five years ago would be worth $69,454 today (with dividends reinvested), compared to $27,109 for GS. Over the past 12 months, GS leads with a +73.4% total return vs BMA's -6.5%. The 3-year compound annual growth rate (CAGR) favors BMA at 70.7% vs GS's 44.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -11.6% | +3.0% |
| 1-Year ReturnPast 12 months | -6.5% | +73.4% |
| 3-Year ReturnCumulative with dividends | +397.7% | +198.7% |
| 5-Year ReturnCumulative with dividends | +594.5% | +171.1% |
| 10-Year ReturnCumulative with dividends | +56.3% | +536.1% |
| CAGR (3Y)Annualised 3-year return | +70.7% | +44.0% |
Risk & Volatility
GS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
GS is the less volatile stock with a 1.47 beta — it tends to amplify market swings less than BMA's 1.76 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GS currently trades 95.2% from its 52-week high vs BMA's 72.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.76x | 1.47x |
| 52-Week HighHighest price in past year | $106.15 | $984.70 |
| 52-Week LowLowest price in past year | $38.30 | $547.06 |
| % of 52W HighCurrent price vs 52-week peak | +72.5% | +95.2% |
| RSI (14)Momentum oscillator 0–100 | 35.3 | 55.0 |
| Avg Volume (50D)Average daily shares traded | 364K | 2.0M |
Analyst Outlook
Evenly matched — BMA and GS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates BMA as "Buy" and GS as "Hold". Consensus price targets imply 68.9% upside for BMA (target: $130) vs 6.2% for GS (target: $996). For income investors, BMA offers the higher dividend yield at 6.81% vs GS's 1.44%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $130.00 | $995.89 |
| # AnalystsCovering analysts | 14 | 55 |
| Dividend YieldAnnual dividend ÷ price | +6.8% | +1.4% |
| Dividend StreakConsecutive years of raises | 1 | 12 |
| Dividend / ShareAnnual DPS | $7302.65 | $13.48 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.5% |
GS leads in 2 of 6 categories (Income & Cash Flow, Risk & Volatility). BMA leads in 2 (Valuation Metrics, Profitability & Efficiency). 2 tied.
BMA vs GS: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is BMA or GS a better buy right now?
For growth investors, The Goldman Sachs Group, Inc.
(GS) is the stronger pick with 17. 0% revenue growth year-over-year, versus -33. 3% for Banco Macro S. A. (BMA). Banco Macro S. A. (BMA) offers the better valuation at 21. 1x trailing P/E (0. 0x forward), making it the more compelling value choice. Analysts rate Banco Macro S. A. (BMA) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BMA or GS?
On trailing P/E, Banco Macro S.
A. (BMA) is the cheapest at 21. 1x versus The Goldman Sachs Group, Inc. at 23. 1x. On forward P/E, Banco Macro S. A. is actually cheaper at 0. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Banco Macro S. A. wins at 0. 00x versus The Goldman Sachs Group, Inc. 's 1. 13x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BMA or GS?
Over the past 5 years, Banco Macro S.
A. (BMA) delivered a total return of +594. 5%, compared to +171. 1% for The Goldman Sachs Group, Inc. (GS). Over 10 years, the gap is even starker: GS returned +536. 1% versus BMA's +56. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BMA or GS?
By beta (market sensitivity over 5 years), The Goldman Sachs Group, Inc.
(GS) is the lower-risk stock at 1. 47β versus Banco Macro S. A. 's 1. 76β — meaning BMA is approximately 20% more volatile than GS relative to the S&P 500. On balance sheet safety, Banco Macro S. A. (BMA) carries a lower debt/equity ratio of 11% versus 5% for The Goldman Sachs Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BMA or GS?
By revenue growth (latest reported year), The Goldman Sachs Group, Inc.
(GS) is pulling ahead at 17. 0% versus -33. 3% for Banco Macro S. A. (BMA). On earnings-per-share growth, the picture is similar: The Goldman Sachs Group, Inc. grew EPS 77. 3% year-over-year, compared to -44. 6% for Banco Macro S. A.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BMA or GS?
The Goldman Sachs Group, Inc.
(GS) is the more profitable company, earning 11. 3% net margin versus 5. 0% for Banco Macro S. A. — meaning it keeps 11. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GS leads at 14. 5% versus 5. 6% for BMA. At the gross margin level — before operating expenses — BMA leads at 68. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BMA or GS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Banco Macro S. A. (BMA) is the more undervalued stock at a PEG of 0. 00x versus The Goldman Sachs Group, Inc. 's 1. 13x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Banco Macro S. A. (BMA) trades at 0. 0x forward P/E versus 15. 8x for The Goldman Sachs Group, Inc. — 15. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BMA: 68. 9% to $130. 00.
08Which pays a better dividend — BMA or GS?
All stocks in this comparison pay dividends.
Banco Macro S. A. (BMA) offers the highest yield at 6. 8%, versus 1. 4% for The Goldman Sachs Group, Inc. (GS).
09Is BMA or GS better for a retirement portfolio?
For long-horizon retirement investors, The Goldman Sachs Group, Inc.
(GS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1. 4% yield, +536. 1% 10Y return). Banco Macro S. A. (BMA) carries a higher beta of 1. 76 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (GS: +536. 1%, BMA: +56. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BMA and GS?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BMA is a small-cap income-oriented stock; GS is a large-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.